Q1 Revenue at $200.35M, Below Consensus of $208.52M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 05 2026
0mins
Reports Q1 revenue $200.35M, consensus $208.52M.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy JAN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on JAN
Wall Street analysts forecast JAN stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 26.760
Low
Averages
High
Current: 26.760
Low
Averages
High
About JAN
ALT5 Sigma Corporation is a fintech company providing blockchain-powered technologies for tokenization, trading, clearing settlement, payment and safe keeping of digital assets. The Company, through its subsidiary, ALT5 Sigma, Inc., provides blockchain-powered technologies to enable migration to a global financial paradigm. It offers two platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. The Company also owns Mswipe, which is a payment solutions provider offering multi-currency, fiat payment card services along with crypto-enabled capabilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Conversant Capital Increases Stake in Sonida Senior Living by $178.71 Million
- Share Acquisition: On May 15, 2026, Conversant Capital disclosed an acquisition of 5,341,221 shares of Sonida Senior Living (NYSE:SNDA), valued at approximately $178.71 million, indicating strong confidence in the company's prospects.
- Portfolio Focus: Following the acquisition, Conversant Capital's stake in Sonida is valued at $471.04 million, representing 63.3% of its assets under management, suggesting the fund's bullish outlook on the long-term growth potential of the senior housing market.
- Performance Surge: Sonida reported over a 30% year-over-year revenue increase to $122.6 million in Q1 2026, with same-store occupancy rising by 220 basis points to 87.2%, demonstrating significant operational improvements post-acquisition.
- Risks and Opportunities: Although Sonida's net loss widened to $41.2 million due to merger-related costs and debt financing, the accelerating demand from America's aging population presents a compelling opportunity for long-term investors to consider.
See More
Healthpeak Properties Q1 Beats Estimates, Raises Full-Year Guidance
- Earnings Beat: Healthpeak Properties reported Q1 adjusted FFO of $0.45, surpassing the $0.43 consensus, although it declined from $0.47 in Q4 2025, indicating resilience amid market fluctuations.
- Revenue Growth: Q1 revenue reached $753 million, exceeding the $693.1 million forecast, and increased from $719.4 million in the previous quarter and $702.9 million a year ago, reflecting strong performance in the healthcare real estate sector.
- Successful IPO: During the quarter, Healthpeak completed the IPO of Janus Living, generating approximately $880 million in net proceeds, showcasing the company's strong appeal in the capital markets and investor confidence.
- Leasing Activity: Outpatient medical and lab new and renewal lease executions totaled 1.2 million square feet, with renewal cash releasing spreads at 5.4%, demonstrating the company's stability and growth potential in the leasing market.
See More
Analysis of High-Yield Stocks in Healthcare Sector
- Perrigo's High Yield and Risks: With a forward dividend yield of 9.6%, Perrigo's stock has plummeted over 87.5% in the past decade, indicating the uncertainty behind its high yield, which investors must carefully assess as a potential value trap.
- Healthpeak's Restructuring Potential: As one of the largest healthcare REITs, Healthpeak Properties owns over 700 healthcare-related properties, currently offering a forward dividend yield of 7.1%, and its newly formed Janus Living could enhance its market value, attracting investors focused on capital growth.
- Dividend Cuts at Medical Properties Trust: Medical Properties Trust has a forward dividend yield of approximately 6.8%, but it has reduced its dividend twice due to the bankruptcy of major tenant Steward Health Care, highlighting its financial challenges.
- Financial Stability and Future Outlook: Despite facing tenant financial issues and over $2 billion in debt maturities, Medical Properties Trust's latest quarterly results show normalized funds from operations of $0.18 per share, suggesting it can sustain its current dividend for now.
See More
Janus Living Initiated with Buy Ratings, Shares Rise
- Rating Upgrade: Janus Living (JAN) was initiated with a Buy rating by BofA Securities and an Overweight rating by KeyBanc Capital Markets, resulting in a 2.58% increase in share price to $24.61, reflecting market optimism about its prospects.
- Portfolio Overview: JAN currently operates 34 senior housing communities with approximately 10,400 units across 10 states, including 15 Life Plan/CCRCs and 19 SHOP communities, showcasing its extensive footprint in the senior housing market.
- Financial Health: The company has no outstanding debt and approximately $1.4 billion in available liquidity post-IPO, enabling it to deploy IPO proceeds at attractive yields of 6-7% within the first year, demonstrating strong financial strength and growth potential.
- Earnings Expectations: KeyBanc established a normalized FFO estimate of $0.96 per share for 2026 and $1.13 for 2027, both exceeding the consensus estimates of $0.67 and $0.86, indicating JAN's profitability and growth outlook in the senior housing sector.
See More
Latest Rating Changes on Wall Street
- Infleqtion Coverage Initiation: Citigroup initiates coverage of quantum computing firm Infleqtion with a Buy/High Risk rating and a $20 price target, highlighting its uniqueness in the quantum computing sector, which may attract investor interest.
- SAP Downgrade: Piper Sandler downgrades SAP from Overweight to Neutral, citing challenges in the macroeconomic environment and anticipating lower valuation multiples as the software industry transitions from SaaS to AI.
- Positive Catalysts for Alphabet: Citigroup adds a 90-day Catalyst Watch on Alphabet, expecting upcoming product updates during events like Google Cloud Next and YouTube Brandcast to drive stock price appreciation.
- Biogen Upgrade: Piper Sandler upgrades Biogen from Neutral to Overweight, raising the price target from $177 to $214, reflecting confidence in its growth potential moving forward.
See More
Cantor Fitzgerald Initiates Coverage on JAN and SNDA with Overweight Rating
- Coverage Initiation: Cantor Fitzgerald has initiated coverage on Janus Living (JAN) and Sonida Senior Living (SNDA) with an Overweight rating, indicating analysts' optimistic outlook on the growth potential of these emerging companies.
- Market Opportunity Analysis: Analysts highlight that JAN and SNDA, focusing primarily on senior housing operations, provide unique investment opportunities for investors, particularly in a market dominated by large-cap REITs, filling a gap in the demand for pure-play senior housing platforms.
- Growth Potential Assessment: While large REITs require billions in investments to drive earnings growth, analysts believe JAN and SNDA could serve as more cost-effective investment alternatives amidst future market fluctuations due to their smaller market capitalizations.
- Rating Comparison: Despite Janus Living being rated Hold on Seeking Alpha and Sonida Senior Living also rated Hold by the Wall Street community and SA's Quant Ratings system, this reflects a cautious market sentiment towards both companies.
See More
Conversant Capital Increases Stake in Sonida Senior Living by $178.71 Million
- Share Acquisition: On May 15, 2026, Conversant Capital disclosed an acquisition of 5,341,221 shares of Sonida Senior Living (NYSE:SNDA), valued at approximately $178.71 million, indicating strong confidence in the company's prospects.
- Portfolio Focus: Following the acquisition, Conversant Capital's stake in Sonida is valued at $471.04 million, representing 63.3% of its assets under management, suggesting the fund's bullish outlook on the long-term growth potential of the senior housing market.
- Performance Surge: Sonida reported over a 30% year-over-year revenue increase to $122.6 million in Q1 2026, with same-store occupancy rising by 220 basis points to 87.2%, demonstrating significant operational improvements post-acquisition.
- Risks and Opportunities: Although Sonida's net loss widened to $41.2 million due to merger-related costs and debt financing, the accelerating demand from America's aging population presents a compelling opportunity for long-term investors to consider.
See More
Healthpeak Properties Q1 Beats Estimates, Raises Full-Year Guidance
- Earnings Beat: Healthpeak Properties reported Q1 adjusted FFO of $0.45, surpassing the $0.43 consensus, although it declined from $0.47 in Q4 2025, indicating resilience amid market fluctuations.
- Revenue Growth: Q1 revenue reached $753 million, exceeding the $693.1 million forecast, and increased from $719.4 million in the previous quarter and $702.9 million a year ago, reflecting strong performance in the healthcare real estate sector.
- Successful IPO: During the quarter, Healthpeak completed the IPO of Janus Living, generating approximately $880 million in net proceeds, showcasing the company's strong appeal in the capital markets and investor confidence.
- Leasing Activity: Outpatient medical and lab new and renewal lease executions totaled 1.2 million square feet, with renewal cash releasing spreads at 5.4%, demonstrating the company's stability and growth potential in the leasing market.
See More
Analysis of High-Yield Stocks in Healthcare Sector
- Perrigo's High Yield and Risks: With a forward dividend yield of 9.6%, Perrigo's stock has plummeted over 87.5% in the past decade, indicating the uncertainty behind its high yield, which investors must carefully assess as a potential value trap.
- Healthpeak's Restructuring Potential: As one of the largest healthcare REITs, Healthpeak Properties owns over 700 healthcare-related properties, currently offering a forward dividend yield of 7.1%, and its newly formed Janus Living could enhance its market value, attracting investors focused on capital growth.
- Dividend Cuts at Medical Properties Trust: Medical Properties Trust has a forward dividend yield of approximately 6.8%, but it has reduced its dividend twice due to the bankruptcy of major tenant Steward Health Care, highlighting its financial challenges.
- Financial Stability and Future Outlook: Despite facing tenant financial issues and over $2 billion in debt maturities, Medical Properties Trust's latest quarterly results show normalized funds from operations of $0.18 per share, suggesting it can sustain its current dividend for now.
See More
Janus Living Initiated with Buy Ratings, Shares Rise
- Rating Upgrade: Janus Living (JAN) was initiated with a Buy rating by BofA Securities and an Overweight rating by KeyBanc Capital Markets, resulting in a 2.58% increase in share price to $24.61, reflecting market optimism about its prospects.
- Portfolio Overview: JAN currently operates 34 senior housing communities with approximately 10,400 units across 10 states, including 15 Life Plan/CCRCs and 19 SHOP communities, showcasing its extensive footprint in the senior housing market.
- Financial Health: The company has no outstanding debt and approximately $1.4 billion in available liquidity post-IPO, enabling it to deploy IPO proceeds at attractive yields of 6-7% within the first year, demonstrating strong financial strength and growth potential.
- Earnings Expectations: KeyBanc established a normalized FFO estimate of $0.96 per share for 2026 and $1.13 for 2027, both exceeding the consensus estimates of $0.67 and $0.86, indicating JAN's profitability and growth outlook in the senior housing sector.
See More
Latest Rating Changes on Wall Street
- Infleqtion Coverage Initiation: Citigroup initiates coverage of quantum computing firm Infleqtion with a Buy/High Risk rating and a $20 price target, highlighting its uniqueness in the quantum computing sector, which may attract investor interest.
- SAP Downgrade: Piper Sandler downgrades SAP from Overweight to Neutral, citing challenges in the macroeconomic environment and anticipating lower valuation multiples as the software industry transitions from SaaS to AI.
- Positive Catalysts for Alphabet: Citigroup adds a 90-day Catalyst Watch on Alphabet, expecting upcoming product updates during events like Google Cloud Next and YouTube Brandcast to drive stock price appreciation.
- Biogen Upgrade: Piper Sandler upgrades Biogen from Neutral to Overweight, raising the price target from $177 to $214, reflecting confidence in its growth potential moving forward.
See More
Cantor Fitzgerald Initiates Coverage on JAN and SNDA with Overweight Rating
- Coverage Initiation: Cantor Fitzgerald has initiated coverage on Janus Living (JAN) and Sonida Senior Living (SNDA) with an Overweight rating, indicating analysts' optimistic outlook on the growth potential of these emerging companies.
- Market Opportunity Analysis: Analysts highlight that JAN and SNDA, focusing primarily on senior housing operations, provide unique investment opportunities for investors, particularly in a market dominated by large-cap REITs, filling a gap in the demand for pure-play senior housing platforms.
- Growth Potential Assessment: While large REITs require billions in investments to drive earnings growth, analysts believe JAN and SNDA could serve as more cost-effective investment alternatives amidst future market fluctuations due to their smaller market capitalizations.
- Rating Comparison: Despite Janus Living being rated Hold on Seeking Alpha and Sonida Senior Living also rated Hold by the Wall Street community and SA's Quant Ratings system, this reflects a cautious market sentiment towards both companies.
See More
